Administración de Empresas
Saila
Swedish Institute for Health Economics
Lund, SueciaSwedish Institute for Health Economics-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2019
2017
-
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain
Clinical Therapeutics, Vol. 39, Núm. 4, pp. 771-786.e3